Volume 121, Issue 3, Pages 640-645 (September 2001) Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer Suresh T. Chari, George G. Klee, Laurence J. Miller, Massimo Raimondo, Eugene P. DiMagno Gastroenterology Volume 121, Issue 3, Pages 640-645 (September 2001) DOI: 10.1053/gast.2001.27210 Copyright © 2001 American Gastroenterological Association Terms and Conditions
Fig. 1 Scatter diagram of serum IAPP in patient groups. “Others” includes bile duct and ampulary tumors, cysts, and benign pancreatic tumors. The line represents the cutoff value for IAPP used in the study. *P ≤ 0.001 vs. all other groups. AP, acute pancreatitis; CP, chronic pancreatitis; PC, pancreatic cancer. Gastroenterology 2001 121, 640-645DOI: (10.1053/gast.2001.27210) Copyright © 2001 American Gastroenterological Association Terms and Conditions
Fig. 2 Sensitivity (■) and specificity (▧) of IAPP for detection of pancreatic cancer at various cutoff values. Gastroenterology 2001 121, 640-645DOI: (10.1053/gast.2001.27210) Copyright © 2001 American Gastroenterological Association Terms and Conditions
Fig. 3 Relationship between IAPP levels and diabetes in patient groups. ◊, No diabetes; ○, diabetes. Gastroenterology 2001 121, 640-645DOI: (10.1053/gast.2001.27210) Copyright © 2001 American Gastroenterological Association Terms and Conditions
Fig. 4 Sensitivity (■) and specificity (▧) of CA 19-9 for detection of pancreatic cancer at various cutoff values. Gastroenterology 2001 121, 640-645DOI: (10.1053/gast.2001.27210) Copyright © 2001 American Gastroenterological Association Terms and Conditions
Fig. 5 Interval from diagnosis of diabetes to diagnosis of pancreatic cancer. Gastroenterology 2001 121, 640-645DOI: (10.1053/gast.2001.27210) Copyright © 2001 American Gastroenterological Association Terms and Conditions